Application of SLE-DAS to assess subcutaneous belimumab efficacy in a cohort of systemic lupus erythematosus patients

To assess the efficacy of subcutaneous (sc) belimumab (BLM) by the application of SLE-DAS in a monocentric SLE cohort. We evaluated SLE patients treated with sc BLM from March 2019. Disease activity has been assessed by SLEDAI-2k, SLE-DAS and PGA (Physician Global Assessment) in all the established...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical and experimental rheumatology 2024-07, Vol.42 (7), p.1491
Hauptverfasser:	Ceccarelli, Fulvia, Picciariello, Licia, Natalucci, Francesco, Moretti, Valeria, Spinelli, Francesca Romana, Alessandri, Cristiano, Conti, Fabrizio
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!